Source: Science Signaling. Unidades: FCFRP, IQ, ICB
Subjects: DOR CRÔNICA, ANALGÉSICOS, ANATOMIA, FOSFOLIPASES, MUTAÇÃO GENÉTICA
ABNT
MORAES, Beatriz Caroline de et al. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target. Science Signaling, v. 15, n. 731, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1126/scisignal.abm6046. Acesso em: 21 ago. 2024.APA
Moraes, B. C. de, Ribeiro Filho, H. V., Roldão, A. P., Toniolo, E. F., Carretero, G. P. B., Sgro, G. G., et al. (2022). Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target. Science Signaling, 15( 731), 1-16. doi:10.1126/scisignal.abm6046NLM
Moraes BC de, Ribeiro Filho HV, Roldão AP, Toniolo EF, Carretero GPB, Sgro GG, Batista FAH, Berardi DE, Oliveira VR da S, Tomasin R, Vieceli FM, Pramio DT, Bruni-Cardoso A, Figueira ACM, Farah CS, Devi LA, Dale CS, Oliveira PSL de, Schechtman D. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target [Internet]. Science Signaling. 2022 ; 15( 731): 1-16.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1126/scisignal.abm6046Vancouver
Moraes BC de, Ribeiro Filho HV, Roldão AP, Toniolo EF, Carretero GPB, Sgro GG, Batista FAH, Berardi DE, Oliveira VR da S, Tomasin R, Vieceli FM, Pramio DT, Bruni-Cardoso A, Figueira ACM, Farah CS, Devi LA, Dale CS, Oliveira PSL de, Schechtman D. Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCy as an analgesic drug target [Internet]. Science Signaling. 2022 ; 15( 731): 1-16.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1126/scisignal.abm6046